Skip to main content

1 Result(s)

within Mark Bolding Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas

    Bevacizumab is widely used for treatment of high-grade gliomas and other malignancies. Because bevacizumab has been shown to be associated with neurocognitive decline, this study is designed to investigate whe...

    Asim K. Bag, Hyunki Kim, Yi Gao, Mark Bolding, Paula P. Warren… in Journal of Neuro-Oncology (2015)